Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NTR Stock Summary
Top 10 Correlated ETFs
NTR
In the News
Is It Worth Investing in Nutrien (NTR) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Nutrien (NTR) Declares TSX Clearance of Shares Buyback Program
Nutrien (NTR) receives approval for a new share repurchase program, allowing it to buy back up to 5% of outstanding shares to return capital to shareholders.
Food Security Shakeup: 3 AgriTech Stocks to Own
Since the start of the war in Ukraine two years ago, the importance of food security has never been clearer. The interconnected nature of food production worldwide has made agriculture a cornerstone of the global economy.
Nutrien (NTR) Ups Quarterly Dividend, Announces Share Buyback
The board of Nutrien (NTR) authorizes the purchase of up to 5% of the company's issued and outstanding common shares over a 12-month period.
Nutrien's (NTR) Q4 Earnings Miss, Revenues Beat Estimates
Nutrien (NTR) earnings miss and sales beat their respective estimates amid lower selling prices across all segments in Q4.
Nutrien (NTR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nutrien (NTR) Q4 Earnings Lag Estimates
Nutrien (NTR) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $2.02 per share a year ago.
Is a Surprise Coming for Nutrien (NTR) This Earnings Season?
Nutrien (NTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nutrien Announces Mark Thompson and Jeff Tarsi as Speakers at the BofA Investor Conference
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Mark Thompson, Nutrien's Executive Vice President and Chief Commercial Officer, and Mr. Jeff Tarsi, Nutrien's Executive Vice President and President, Global Retail, will be speaking at the BofA 2024 Securities Global Agriculture and Materials Conference on Wednesday, February 28 at 9:50 a.m. EST. The fireside chat will be video cast and available on the Company's website at https://www.nutrien.co.
Nutrien Announces Ken Seitz as a Speaker at the BMO Investor Conference
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Ken Seitz, Nutrien's President and Chief Executive Officer, will be speaking at the BMO Global Metals, Mining and Critical Minerals Conference on Tuesday, February 27 at 8:00 a.m. EST. The fireside chat will be video cast and available on the Company's website at https://www.nutrien.com/investors/events. About Nutrien Nutrien is a leading provider of crop inputs and services, helping to safely an.
NTR Financial details
NTR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 34.39 | 36.7 | 48.65 | 66.31 | 59.61 | |
Net income per share | 1.7 | 0.81 | 5.53 | 13.41 | 2.53 | |
Operating cash flow per share | 6.29 | 5.83 | 6.82 | 14.2 | 10.39 | |
Free cash flow per share | 3.05 | 3.11 | 3.69 | 9.93 | 4.91 | |
Cash per share | 1.15 | 2.55 | 0.88 | 1.58 | 1.89 | |
Book value per share | 39.28 | 39.26 | 41.52 | 45.19 | 50.42 | |
Tangible book value per share | 14.52 | 13.66 | 16.04 | 19.6 | 21.76 | |
Share holders equity per share | 39.28 | 39.26 | 41.52 | 45.19 | 50.42 | |
Interest debt per share | 19.94 | 20.85 | 19.9 | 21.74 | 24.95 | |
Market cap | 27.9B | 27.43B | 42.84B | 41.72B | 27.96B | |
Enterprise value | 38.33B | 37.34B | 53.19B | 52.75B | 39.53B | |
P/E ratio | 28.12 | 59.77 | 13.59 | 5.45 | 22.23 | |
Price to sales ratio | 1.39 | 1.31 | 1.55 | 1.1 | 0.94 | |
POCF ratio | 7.61 | 8.26 | 11.02 | 5.14 | 5.42 | |
PFCF ratio | 15.73 | 15.46 | 20.37 | 7.36 | 11.46 | |
P/B Ratio | 1.22 | 1.23 | 1.81 | 1.62 | 1.12 | |
PTB ratio | 1.22 | 1.23 | 1.81 | 1.62 | 1.12 | |
EV to sales | 1.91 | 1.79 | 1.92 | 1.39 | 1.34 | |
Enterprise value over EBITDA | 9.84 | 10.36 | 7.67 | 4.37 | 6.44 | |
EV to operating cash flow | 10.46 | 11.24 | 13.69 | 6.5 | 7.66 | |
EV to free cash flow | 21.61 | 21.05 | 25.29 | 9.3 | 16.21 | |
Earnings yield | 0.04 | 0.02 | 0.07 | 0.18 | 0.04 | |
Free cash flow yield | 0.06 | 0.06 | 0.05 | 0.14 | 0.09 | |
Debt to equity | 0.49 | 0.51 | 0.46 | 0.46 | 0.46 | |
Debt to assets | 0.24 | 0.24 | 0.22 | 0.22 | 0.22 | |
Net debt to EBITDA | 2.68 | 2.75 | 1.49 | 0.91 | 1.88 | |
Current ratio | 1.17 | 1.35 | 1.11 | 1.14 | 1.17 | |
Interest coverage | 3.69 | 3.1 | 9.8 | 21.97 | 4.44 | |
Income quality | 3.69 | 7.24 | 1.22 | 1.06 | 4.03 | |
Dividend Yield | 0.04 | 0.04 | 0.02 | 0.02 | 0.04 | |
Payout ratio | 1.03 | 2.24 | 0.33 | 0.13 | 0.84 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.31 | 0.29 | 0.27 | 0.27 | |
Capex to operating cash flow | -0.52 | -0.47 | -0.46 | -0.3 | -0.53 | |
Capex to revenue | -0.09 | -0.07 | -0.06 | -0.06 | -0.09 | |
Capex to depreciation | -1.05 | -0.78 | -0.91 | -1.21 | -1.21 | |
Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
Graham number | 38.8 | 26.68 | 71.91 | 116.76 | 53.62 | |
ROIC | 0.04 | 0.06 | 0.1 | 0.21 | 0.07 | |
Return on tangible assets | 0.03 | 0.01 | 0.09 | 0.19 | 0.03 | |
Graham Net | -31.11 | -31.99 | -32.59 | -33.89 | -38.86 | |
Working capital | 1.54B | 2.99B | 1.4B | 2.06B | 2.04B | |
Tangible asset value | 8.46B | 7.78B | 9.14B | 11.2B | 10.74B | |
Net current asset value | -13.27B | -13.36B | -12.41B | -12.38B | -13.31B | |
Invested capital | 0.49 | 0.51 | 0.46 | 0.46 | 0.46 | |
Average receivables | 3.44B | 3.56B | 4.47B | 5.78B | 5.78B | |
Average payables | 3.53B | 4.22B | 4.8B | 5.49B | 5.62B | |
Average inventory | 4.95B | 4.95B | 5.63B | 6.98B | 6.97B | |
Days sales outstanding | 64.57 | 62.52 | 70.68 | 59.68 | 66.25 | |
Days payables outstanding | 100.52 | 102.84 | 103.28 | 94.21 | 91.29 | |
Days of inventory on hand | 124.53 | 114.84 | 126.19 | 124.03 | 105.6 | |
Receivables turnover | 5.65 | 5.84 | 5.16 | 6.12 | 5.51 | |
Payables turnover | 3.63 | 3.55 | 3.53 | 3.87 | 4 | |
Inventory turnover | 2.93 | 3.18 | 2.89 | 2.94 | 3.46 | |
ROE | 0.04 | 0.02 | 0.13 | 0.3 | 0.05 | |
Capex per share | -3.25 | -2.72 | -3.13 | -4.27 | -5.48 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 14.58 | 12.19 | 23.53 | 11.39 | 11.77 | |
Net income per share | 2.15 | 1.14 | 0.89 | 0.15 | 0.35 | |
Operating cash flow per share | 9.16 | -1.71 | 4.53 | -0.95 | 8.55 | |
Free cash flow per share | 7.28 | -2.61 | 2.96 | -2.19 | 6.83 | |
Cash per share | 1.74 | 2.94 | 1.49 | 1.12 | 1.89 | |
Book value per share | 49.96 | 50.4 | 51.3 | 50.85 | 50.61 | |
Tangible book value per share | 21.67 | 21.11 | 22.47 | 22.04 | 21.84 | |
Share holders equity per share | 49.96 | 50.4 | 51.3 | 50.85 | 50.61 | |
Interest debt per share | 23.44 | 30.78 | 27.92 | 30.72 | 23.71 | |
Market cap | 37.74B | 37.01B | 29.25B | 30.54B | 27.86B | |
Enterprise value | 48.77B | 50.79B | 42.14B | 44.97B | 39.42B | |
P/E ratio | 8.49 | 16.2 | 16.62 | 101.8 | 40.49 | |
Price to sales ratio | 5.01 | 6.06 | 2.51 | 5.42 | 4.79 | |
POCF ratio | 7.97 | -43.14 | 13.04 | -65.12 | 6.59 | |
PFCF ratio | 10.03 | -28.3 | 19.93 | -28.17 | 8.25 | |
P/B Ratio | 1.46 | 1.47 | 1.15 | 1.21 | 1.11 | |
PTB ratio | 1.46 | 1.47 | 1.15 | 1.21 | 1.11 | |
EV to sales | 6.47 | 8.32 | 3.62 | 7.99 | 6.77 | |
Enterprise value over EBITDA | 22.7 | 35.9 | 16.42 | 42.83 | 30.96 | |
EV to operating cash flow | 10.3 | -59.2 | 18.79 | -95.89 | 9.32 | |
EV to free cash flow | 12.96 | -38.83 | 28.71 | -41.49 | 11.67 | |
Earnings yield | 0.03 | 0.02 | 0.02 | 0 | 0.01 | |
Free cash flow yield | 0.1 | -0.04 | 0.05 | -0.04 | 0.12 | |
Debt to equity | 0.46 | 0.6 | 0.54 | 0.6 | 0.46 | |
Debt to assets | 0.22 | 0.27 | 0.25 | 0.29 | 0.22 | |
Net debt to EBITDA | 5.13 | 9.74 | 5.02 | 13.75 | 9.08 | |
Current ratio | 1.14 | 1.18 | 1.26 | 1.25 | 1.17 | |
Interest coverage | 8.66 | 5.52 | 9.85 | 2.42 | 3.16 | |
Income quality | 4.24 | -1.49 | 5.01 | -5.72 | 23.92 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.23 | 0.43 | 0.6 | 3.48 | 1.56 | |
Sales general and administrative to revenue | 0.02 | 0.03 | 0.01 | 0.03 | 0.04 | |
Research and developement to revenue | 0.02 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.27 | 0.26 | 0.27 | 0.27 | 0.27 | |
Capex to operating cash flow | -0.21 | 0.52 | -0.35 | 1.31 | -0.2 | |
Capex to revenue | -0.13 | -0.07 | -0.07 | -0.11 | -0.15 | |
Capex to depreciation | -1.87 | -0.91 | -1.39 | -1.11 | -1.46 | |
Stock based compensation to revenue | -0.01 | 0 | -0.01 | 0.01 | 0 | |
Graham number | 49.18 | 35.95 | 32.02 | 13.17 | 19.9 | |
ROIC | 0.03 | 0.02 | 0.02 | 0.01 | 0.04 | |
Return on tangible assets | 0.03 | 0.01 | 0.01 | 0 | 0 | |
Graham Net | -37.46 | -40.67 | -36.85 | -36.62 | -39.01 | |
Working capital | 2.06B | 2.8B | 3.26B | 2.78B | 2.04B | |
Tangible asset value | 11.2B | 10.58B | 11.13B | 10.9B | 10.74B | |
Net current asset value | -12.38B | -13.02B | -12.47B | -12.94B | -13.31B | |
Invested capital | 0.46 | 0.6 | 0.54 | 0.6 | 0.46 | |
Average receivables | 7.39B | 6.1B | 7.3B | 8.15B | 6.54B | |
Average payables | 6.78B | 8.21B | 10.04B | 8.04B | 6.04B | |
Average inventory | 7.09B | 8.74B | 7.96B | 5.62B | 5.74B | |
Days sales outstanding | 74 | 88.56 | 66.38 | 123.28 | 83.04 | |
Days payables outstanding | 112.76 | 227.86 | 100.24 | 148.83 | 122.49 | |
Days of inventory on hand | 148.45 | 211.42 | 64.28 | 116.19 | 141.7 | |
Receivables turnover | 1.22 | 1.02 | 1.36 | 0.73 | 1.08 | |
Payables turnover | 0.8 | 0.39 | 0.9 | 0.6 | 0.73 | |
Inventory turnover | 0.61 | 0.43 | 1.4 | 0.77 | 0.64 | |
ROE | 0.04 | 0.02 | 0.02 | 0 | 0.01 | |
Capex per share | -1.88 | -0.9 | -1.56 | -1.24 | -1.72 |
NTR Frequently Asked Questions
What is Nutrien Ltd. stock symbol ?
Nutrien Ltd. is a CA stock , located in Saskatoon of Sk and trading under the symbol NTR
Is Nutrien Ltd. buy or a sell ?
18 stock analysts have 18 predictions with a medium analyst target price of $95.52. The lowest prediction is $62 and the highest is $135
What is NTR stock prediction ?
With a median analyst target price of $62, 1 stock analysts have made 1 forecasts in last 90 days. $62 is the lowest and $62 is the greatest projection.
What is Nutrien Ltd. stock quote today ?
Nutrien Ltd. stock price is $54.37 today.
Is Nutrien Ltd. stock public?
Yes, Nutrien Ltd. is a publicly traded company.